Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 3496 AL 3510

Functional Neuroanatomy of the Normal and Pathological Basal Ganglia

Lanciego JL, Obeso JA.

Cold Spring Harb Perspect Med. 2026 Jan 5;16(1):a041617. doi: 10.1101/cshperspect.a041617.

[Autophagy and Neurological Diseases]

Shimizu T, Mizushima N.

Brain Nerve. 2026 Jan;78(1):65-72. doi: 10.11477/mf.188160960780010065.

LAPTM proteins in neurological disorders - Autophagy-lysosome dysfunction and therapeutic targets: A review

Wu B, Niu Z, Sui Y.

Biomol Biomed. 2026 Feb 10;26(9):1426-1441. doi: 10.17305/bb.2026.13624.

Probiotic and Dietary Supplements Intervention in Age-Related Neurodegenerative Disorders

D'Anniballe De Salles CB, Prajapati SK, Yadav D, Rennar J, Marcano-Rodriguez A, Yadav H, Jain S.

Microorganisms. 2026 Jan 27;14(2):290. doi: 10.3390/microorganisms14020290.

The therapeutic potential of cytisine and its derivatives in disorders of the central nervous system

Cheng M, Zhu D, Chen S, Jia J, Xu J, Zeng X.

Biochem Pharmacol. 2026 Jun;248:117853. doi: 10.1016/j.bcp.2026.117853. Epub 2026 Feb 26.

Endoplasmic reticulum stress in Parkinson's disease: A pivotal role in cell fate and a therapeutic target

Chen L, Liu F, Sun B, Deng D, Han Y, Wang J, Song J, Wang C, Sun K, Yu H.

Ageing Res Rev. 2026 Jun;118:103096. doi: 10.1016/j.arr.2026.103096. Epub 2026 Mar 7.

The futility of the familiar: rethinking strategies for the development of small molecules for neurodegenerative disorders

Novás M, Matos MJ, Chai CLL.

Expert Opin Drug Discov. 2026 Apr;21(4):375-386. doi: 10.1080/17460441.2026.2646603. Epub 2026 Mar 22.

Dissecting microglial contributions to neurodegenerative disease pathophysiology using human pluripotent stem cells

Kim D, Kondo T, Inoue H.

Stem Cell Reports. 2026 Apr 14;21(4):102866. doi: 10.1016/j.stemcr.2026.102866. Epub 2026 Mar 26.

Lipid droplets in neurodegenerative diseases: pathological drivers and therapeutic vulnerabilities

Papapanagiotou O, Cotton K, Edwards C, Michod D, Crompton L, Craig T, Niklison-Chirou MV.

Cell Death Discov. 2026 Apr 9;12(1):236. doi: 10.1038/s41420-026-03096-w.

The future digital outpatient clinic for movement disorders: from technological innovation to ethical and systemic implementation-a position paper

Koeglsperger T, Höllerhage M, Kassubek J, Woitalla D, Winkler J, Klucken J.

J Neural Transm (Vienna). 2026 May 14. doi: 10.1007/s00702-026-03167-3. Online ahead of print.

PTBP1: A master regulator of neural development and transdifferentiation-promise and pitfalls

Liu Y, Huang Y, Wang Y, Mao M, Huang M.

Biochem Biophys Res Commun. 2026 Jul 23;823:153948. doi: 10.1016/j.bbrc.2026.153948. Epub 2026 May 13.

Importance of the inflammasome in gut-brain axis: from pathological driver to therapeutic target

Sarkar S, Roy S, Choudhury L.

Inflammopharmacology. 2026 May 16. doi: 10.1007/s10787-026-02230-5. Online ahead of print.

Phytoconstituents as Potential Therapeutics against Enzymatic Targets for Neurodegenerative Diseases

Singh H, Pandey VP.

Curr Protein Pept Sci. 2026;27(1):46-65. doi: 10.2174/0113892037350938250514110643.

Diagnostics of Synucleinopathies by Protein Amplification Methods: Methodological and Bibliometric Analysis

Groshkov AA, Kolotyeva NA, Tregub PP, Zhdankina VI, Komleva YK, Salmina AB, Illarioshkin SN.

Biochemistry (Mosc). 2026 Jan;91(1):1-16. doi: 10.1134/S000629792560214X.

[Neurogenic bladder]

Dequirez PL, Biardeau X, Phé V.

Rev Prat. 2026 Feb;76(2):198-204.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias